New Perspectives for the Treatment of Cholestasis: Lessons from Basic Science Applied Clinically

Overview

Journal J Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2007 Jan 16

PMID 17223219

Citations 31

Authors

James L Boyer

Affiliations

Soon will be listed here.

Citing Articles

Vincamine alleviates intrahepatic cholestasis in rats through modulation of NF-kB/PDGF/klf6/PPARγ and PI3K/Akt pathways.

Alaaeldin R, Eisa Y, El-Rehany M, Fathy M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7981-7994.

PMID: 38761209 PMC: 11449999. DOI: 10.1007/s00210-024-03119-2.

Chishao () alleviates intra-hepatic cholestasis by modulating NTCP in rats.

Sun X, Fang J, Fang N Front Pharmacol. 2024; 15:1341651.

PMID: 38362143 PMC: 10867832. DOI: 10.3389/fphar.2024.1341651.

Acute and subacute hepatotoxicity of genipin in mice and its potential mechanism.

Wang S, Ge S, Chen Y, Zhou F, Wang J, Chen L Heliyon. 2023; 9(11):e21834.

PMID: 38027867 PMC: 10663932. DOI: 10.1016/j.heliyon.2023.e21834.

Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid Receptor.

Xia Y, Yan S, Chang Y, Yin J, Li H, Yan S Evid Based Complement Alternat Med. 2022; 2022:1589388.

PMID: 36506808 PMC: 9729052. DOI: 10.1155/2022/1589388.

Ginsenosides Restore Lipid and Redox Homeostasis in Mice with Intrahepatic Cholestasis through SIRT1/AMPK Pathways.

Li G, Xu Y, Gao Q, Guo S, Zu Y, Wang X Nutrients. 2022; 14(19).

PMID: 36235592 PMC: 9571347. DOI: 10.3390/nu14193938.

References

Assem M, Schuetz E, Leggas M, Sun D, Yasuda K, Reid G . Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem. 2004; 279(21):22250-7. DOI: 10.1074/jbc.M314111200. View

Bloomer J, Boyer J . Phenobarbital effects in cholestatic liver diseases. Ann Intern Med. 1975; 82(3):310-7. DOI: 10.7326/0003-4819-82-3-310. View

Carulli N, Ponz de Leon M, Podda M, Zuin M, Strata A, Frigerio G . Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial. J Clin Pharmacol. 1981; 21(10):436-42. DOI: 10.1002/j.1552-4604.1981.tb01746.x. View

Albers J, Grundy S, Cleary P, Small D, Lachin J, SCHOENFIELD L . National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology. 1982; 82(4):638-46. View

Ghent C, Carruthers S . Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988; 94(2):488-93. DOI: 10.1016/0016-5085(88)90442-8. View

Bachs L, Pares A, Elena M, Piera C, Rodes J . Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet. 1989; 1(8638):574-6. DOI: 10.1016/s0140-6736(89)91608-5. View

Cynamon H, Andres J, Iafrate R . Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990; 98(4):1013-6. DOI: 10.1016/0016-5085(90)90027-x. View

Wietholtz H, Marschall H, Sjovall J, Matern S . Stimulation of bile acid 6 alpha-hydroxylation by rifampin. J Hepatol. 1996; 24(6):713-8. DOI: 10.1016/s0168-8278(96)80268-6. View

Kullak-Ublick G, Beuers U, Fahney C, Hagenbuch B, Meier P, Paumgartner G . Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology. 1997; 26(4):991-7. DOI: 10.1002/hep.510260429. View

10.

de Vree J, Jacquemin E, Sturm E, Cresteil D, Bosma P, Aten J . Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A. 1998; 95(1):282-7. PMC: 18201. DOI: 10.1073/pnas.95.1.282. View

11.

Trauner M, Meier P, Boyer J . Molecular pathogenesis of cholestasis. N Engl J Med. 1998; 339(17):1217-27. DOI: 10.1056/NEJM199810223391707. View

12.

Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L . The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology. 2004; 127(5):1497-512. DOI: 10.1053/j.gastro.2004.08.001. View

13.

Li T, Chiang J . Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol. 2004; 288(1):G74-84. DOI: 10.1152/ajpgi.00258.2004. View

14.

Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon R, Poupon R . The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005; 128(2):297-303. DOI: 10.1053/j.gastro.2004.11.009. View

15.

Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez J, Moore D . Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci U S A. 2005; 102(6):2063-8. PMC: 548592. DOI: 10.1073/pnas.0409794102. View

16.

Dilger K, Denk A, Heeg M, Beuers U . No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology. 2005; 41(3):595-602. DOI: 10.1002/hep.20568. View

17.

Pauli-Magnus C, Meier P . Hepatocellular transporters and cholestasis. J Clin Gastroenterol. 2005; 39(4 Suppl 2):S103-10. DOI: 10.1097/01.mcg.0000155550.29643.7b. View

18.

Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour B . Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther. 2005; 313(2):604-12. DOI: 10.1124/jpet.104.079665. View

19.

Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D . Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology. 2005; 41(5):1160-72. DOI: 10.1002/hep.20682. View

20.

Belinsky M, Dawson P, Shchaveleva I, Bain L, Wang R, Ling V . Analysis of the in vivo functions of Mrp3. Mol Pharmacol. 2005; 68(1):160-8. DOI: 10.1124/mol.104.010587. View